257 related articles for article (PubMed ID: 22354545)
21. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
Mohamed A; Tzoulis P; Kossler AL; Dosiou C
J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
[TBL] [Abstract][Full Text] [Related]
22. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
[TBL] [Abstract][Full Text] [Related]
23. Tocilizumab for thyroid eye disease.
Hamed Azzam S; Kang S; Salvi M; Ezra DG
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012984. PubMed ID: 30480323
[TBL] [Abstract][Full Text] [Related]
24. Thyroid eye disease: From pathogenesis to targeted therapies.
Yoon JS; Kikkawa DO
Taiwan J Ophthalmol; 2022; 12(1):3-11. PubMed ID: 35399971
[TBL] [Abstract][Full Text] [Related]
25. Management plan and delivery of care in Graves' ophthalmopathy patients.
Yang M; Perros P
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
[TBL] [Abstract][Full Text] [Related]
26. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and prevention of Graves' ophthalmopathy.
Wiersinga WM; Bartalena L
Thyroid; 2002 Oct; 12(10):855-60. PubMed ID: 12487767
[TBL] [Abstract][Full Text] [Related]
28. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology.
Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT
Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729
[TBL] [Abstract][Full Text] [Related]
29. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
Cockerham KP; Padnick-Silver L; Stuertz N; Francis-Sedlak M; Holt RJ
Ophthalmol Ther; 2021 Dec; 10(4):975-987. PubMed ID: 34478126
[TBL] [Abstract][Full Text] [Related]
30. Severe Pediatric Thyroid Eye Disease: Surgical Case Series.
Wu CY; Elner VM; Kahana A
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S186-S188. PubMed ID: 26524159
[TBL] [Abstract][Full Text] [Related]
31. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.
Yu CY; Ford RL; Wester ST; Shriver EM
Indian J Ophthalmol; 2022 Jul; 70(7):2335-2345. PubMed ID: 35791115
[TBL] [Abstract][Full Text] [Related]
32. Future Projections in Thyroid Eye Disease.
Barbesino G; Salvi M; Freitag SK
J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S47-S56. PubMed ID: 36346684
[TBL] [Abstract][Full Text] [Related]
33. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM;
Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684
[TBL] [Abstract][Full Text] [Related]
34. Treating severe Graves' ophthalmopathy.
Bartalena L; Marcocci C; Pinchera A
Baillieres Clin Endocrinol Metab; 1997 Oct; 11(3):521-36. PubMed ID: 9532337
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.
Poon SHL; Cheung JJ; Shih KC; Chan YK
Rev Endocr Metab Disord; 2022 Jun; 23(3):541-567. PubMed ID: 35066781
[TBL] [Abstract][Full Text] [Related]
36. Evolution of thyroid eye disease decompression-dysthyroid optic neuropathy.
Tooley AA; Godfrey KJ; Kazim M
Eye (Lond); 2019 Feb; 33(2):206-211. PubMed ID: 30390053
[TBL] [Abstract][Full Text] [Related]
37. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
Trials; 2013 Apr; 14():119. PubMed ID: 23782950
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal antibodies in the treatment of thyroid eye disease].
Cheredanova VR; Poteshkin YE
Vestn Oftalmol; 2021; 137(4):116-122. PubMed ID: 34410066
[TBL] [Abstract][Full Text] [Related]
39. Medical treatment in thyroid eye disease in 2020.
Khong JJ; McNab A
Br J Ophthalmol; 2021 Mar; 105(3):299-305. PubMed ID: 32447327
[TBL] [Abstract][Full Text] [Related]
40. Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis.
Oeverhaus M; Winkler L; Stähr K; Daser A; Bechrakis N; Stöhr M; Chen Y; Eckstein A
Front Endocrinol (Lausanne); 2023; 14():1160172. PubMed ID: 37082130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
